Cyclophosphamide/dactinomycin/methotrexateMucositis and fatal septic shock due to febrile neutropenia: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1542卷 / 1期

关键词：

D O I：

10.1007/s40278-015-8493-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：85 / 85

相关论文

共 50 条

[1] AntineoplasticsEncephalopathy, febrile neutropenia and septic shock: 2 case reports
[J]. Reactions Weekly, 2019, 1746 (1) : 31 - 31
[2] Multiple drugsFatal febrile neutropenia and septic shock: 2 case reports
[J]. Reactions Weekly, 2021, 1847 (1) : 318 - 318
[3] Cyclophosphamide/rituximabPancytopenia and septic shock: 2 case reports
[J]. Reactions Weekly, 2021, 1870 (1) : 109 - 109
[4] AntineoplasticsFebrile neutropenia, septic shock and pneumonia : 2 case reports
[J]. Reactions Weekly, 2020, 1801 (1) : 32 - 32
[5] Cyclophosphamide/epirubicin/fluorouracilFatigue and febrile neutropenia: 3 case reports
[J]. Reactions Weekly, 2021, 1852 (1) : 149 - 149
[6] Cyclophosphamide/docetaxel/doxorubicin Febrile neutropenia: 3 case reports
[J]. Reactions Weekly, 2021, 1843 (1) : 126 - 126
[7] Cyclophosphamide/dactinomycin/vincristineFebrile neutropenia: case report
[J]. Reactions Weekly, 2022, 1921 (1) : 104 - 104
[8] Cyclophosphamide/prednisone/rituximabLate onset neutropenia and febrile viral syndrome: 2 case reports
[J]. Reactions Weekly, 2017, 1646 (1) : 113 - 113
[9] AmrubicinNeutropenia and febrile neutropenia: 2 case reports
[J]. Reactions Weekly, 2020, 1822 (1) : 37 - 37
[10] AntineoplasticsNeutropenia and febrile neutropenia: 2 case reports
[J]. Reactions Weekly, 2023, 1974 (1) : 51 - 51

← 1 2 3 4 5 →